An Observer-blinded, Randomized Study Comparing the Safety and Immunogenicity of HEPLISAV™ to Licensed Vaccine (Engerix-B®) among Adults with Chronic Kidney Disease

Download

Young A, Korth L, Janssen R, Heyward W, Martin J. An Observer-blinded, Randomized Study Comparing the Safety and Immunogenicity of HEPLISAV™ to Licensed Vaccine (Engerix-B®) among Adults with Chronic Kidney Disease. American Society of Nephrology Renal Week. Denver, CO, Nov 16-21, 2010.